Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin R Green

Showing results (31-40 of 111) with videos related to

Pageof 12
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 12, 2010
Gap junction protein connexin43 (GJA1) in the human glaucomatous optic nerve head and retinaNathan M Kerr, Cameron S Johnson, Colin R Green, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 14, 2015
Neuroprotection in the treatment of glaucoma--A focus on connexin43 gap junction channel blockersYing-Shan Chen, Colin R Green, Helen V Danesh-Meyer, et al.
International Journal of Molecular Sciences|January 5, 2021
Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic RetinopathyHeather Lyon, Avik Shome, Ilva D Rupenthal, et al.
Cell Biology International|October 31, 2021
Blocking connexin43 hemichannels prevents TGF-β2 upregulation and epithelial-mesenchymal transition in retinal pigment epithelial cellsHeather Lyon, Naibo Yin, Ilva D Rupenthal, et al.
Experimental and Molecular Pathology|October 26, 2007
Assessing RNA quality in postmortem human brain tissueIa Chevyreva, Richard L M Faull, Colin R Green, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 1, 2008
Connexin43 antisense oligodeoxynucleotide treatment down-regulates the inflammatory response in an in vitro interphase organotypic culture model of optic nerve ischaemiaHelen V Danesh-Meyer, Rex Huang, Louise F B Nicholson, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 23, 2019
Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal DiseaseMohd Nasir Mat Nor, Ilva D Rupenthal, Colin R Green, et al.
Experimental Cell Research|August 20, 2016
Keratocytes are induced to produce collagen type II: A new strategy for in vivo corneal matrix regenerationCarol Ann Greene, Colin R Green, Michelle E Dickinson, et al.
Analytical Biochemistry|August 30, 2012
Comparison of bidirectional and bicistronic inducible systems for coexpression of connexin genes and fluorescent reportersCarthur K Wan, Shamim B Shaikh, Colin R Green, et al.
International Journal of Molecular Sciences|February 13, 2021
Differential Action of Connexin Hemichannel and Pannexin Channel Therapeutics for Potential Treatment of Retinal DiseasesMohd N Mat Nor, Ilva D Rupenthal, Colin R Green, et al.
Pageof 12

Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 12, 2010
Gap junction protein connexin43 (GJA1) in the human glaucomatous optic nerve head and retinaNathan M Kerr, Cameron S Johnson, Colin R Green, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 14, 2015
Neuroprotection in the treatment of glaucoma--A focus on connexin43 gap junction channel blockersYing-Shan Chen, Colin R Green, Helen V Danesh-Meyer, et al.
International Journal of Molecular Sciences|January 5, 2021
Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic RetinopathyHeather Lyon, Avik Shome, Ilva D Rupenthal, et al.
Cell Biology International|October 31, 2021
Blocking connexin43 hemichannels prevents TGF-β2 upregulation and epithelial-mesenchymal transition in retinal pigment epithelial cellsHeather Lyon, Naibo Yin, Ilva D Rupenthal, et al.
Experimental and Molecular Pathology|October 26, 2007
Assessing RNA quality in postmortem human brain tissueIa Chevyreva, Richard L M Faull, Colin R Green, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 1, 2008
Connexin43 antisense oligodeoxynucleotide treatment down-regulates the inflammatory response in an in vitro interphase organotypic culture model of optic nerve ischaemiaHelen V Danesh-Meyer, Rex Huang, Louise F B Nicholson, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 23, 2019
Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal DiseaseMohd Nasir Mat Nor, Ilva D Rupenthal, Colin R Green, et al.
Experimental Cell Research|August 20, 2016
Keratocytes are induced to produce collagen type II: A new strategy for in vivo corneal matrix regenerationCarol Ann Greene, Colin R Green, Michelle E Dickinson, et al.
Analytical Biochemistry|August 30, 2012
Comparison of bidirectional and bicistronic inducible systems for coexpression of connexin genes and fluorescent reportersCarthur K Wan, Shamim B Shaikh, Colin R Green, et al.
International Journal of Molecular Sciences|February 13, 2021
Differential Action of Connexin Hemichannel and Pannexin Channel Therapeutics for Potential Treatment of Retinal DiseasesMohd N Mat Nor, Ilva D Rupenthal, Colin R Green, et al.
Pageof 12